The clinical significance of branched-chain amino acid (BCAA) dysregulation is highlighted by Maple Syrup Urine Disease (MSUD), a rare inherited metabolic disorder caused by mutations in the branched-chain α-ketoacid dehydrogenase complex (BCKDH). This evidence concerns the gene PPM1K and maple syrup urine disease.